evid
suggest
felin
viru
fiv
caus
pulmonari
overal
object
studi
explor
fivinduc
alter
cell
count
cytokin
gene
express
pulmonari
compart
acut
stage
infect
bronchoalveolar
lavag
bal
cell
collect
fivinfect
control
cat
week
postfiv
infect
phenotyp
cytokin
analysi
major
chang
bal
cellular
popul
follow
fivinfect
develop
neutrophilia
total
bal
cell
count
rel
number
alveolar
macrophag
eosinophil
lymphocyt
remain
similar
group
rtqcpcr
analys
bal
show
constitut
express
tnfa
mrna
peak
acut
stage
infect
declin
tnfa
bioactiv
protein
secret
show
similar
respons
contrast
ifng
express
increas
progress
time
infect
parallel
progress
increas
fivgag
mrna
express
also
differ
cytokin
progress
decreas
number
cat
express
follow
fiv
infect
infect
vitro
fiv
also
caus
increas
veterinari
immunolog
immunopatholog
tnfa
mrna
bioactiv
protein
suggest
increas
cytokin
respons
follow
infect
cat
fiv
intrins
characterist
fivinfect
summari
pulmonari
immun
chang
seen
fivinfect
cat
similar
seen
hivinfect
human
patient
lung
recogn
one
common
target
secondari
infect
includ
mycobacterium
tuberculosi
cryptococcu
neoforman
histoplasma
capsulatum
toxoplasma
gondii
human
viru
hiv
infect
patient
primari
line
defens
pathogen
activ
alveolar
macrophag
beck
shellito
activ
alveolar
macrophag
biphas
process
regul
number
cytokin
gener
antigen
cell
ifng
tnfa
tnfa
earli
activ
occur
result
ifng
tnfa
product
nk
cell
macrophag
sustain
activ
requir
success
control
intracellular
pathogen
depend
upon
develop
immun
respons
ifng
alveolar
macrophag
hivinfect
patient
constitut
produc
cytokin
tnfa
indic
state
activ
agostini
et
al
deni
ghadirian
trentin
et
al
twigg
et
al
yet
abl
success
control
intracellular
pathogen
cytokin
produc
activ
macrophag
may
ratio
particular
cytokin
import
determin
whether
macrophag
function
properli
exampl
although
low
level
constitut
produc
hivinfect
patient
level
could
increas
follow
stimul
staphylococcu
aureu
deni
ghadirian
data
suggest
although
hivinfect
patient
constitut
secret
cytokin
associ
activ
face
secondari
infecti
agent
reach
level
activ
necessari
success
clearanc
organ
possibl
due
failur
mount
protect
immun
respons
felin
viru
fiv
lentiviru
morpholog
biochem
similar
hiv
pathogenesi
clinic
diseas
pattern
parallel
seen
hiv
infect
bendinelli
et
al
english
et
al
acut
infect
follow
variabl
long
asymptomat
period
character
progress
decreas
lymphocyt
result
hallmark
invert
ratio
peripher
blood
bendinelli
et
al
english
et
al
asymptomat
period
follow
develop
aidsassoci
disord
mani
mimic
aid
human
bendinelli
et
al
english
et
al
davidson
et
al
yang
et
al
report
fivinfect
cat
challeng
avirul
strain
gondii
develop
sever
respiratori
diseas
result
mortalityeuthanasia
fivinfect
cat
develop
system
toxoplasmosi
character
necrot
foci
liver
spleen
lymph
node
sever
lung
lesion
accompani
abund
replic
toxoplasma
tachyzoit
readili
notic
site
contrast
cat
develop
transient
mild
clinic
diseas
character
anorexia
lethargi
without
clinic
sign
pulmonari
involv
levi
et
al
examin
peripher
bronchial
lymph
node
normal
fivinfect
cat
follow
challeng
gondii
report
mark
differ
cytokin
two
group
cat
compar
control
cat
challeng
gondii
cell
harvest
lymph
node
fivt
gondii
coinfect
cat
produc
high
level
ifng
mrna
product
dean
pedersen
also
report
elev
level
ifng
mrna
lymph
node
fivinfect
cat
pulmonari
macrophag
microbicid
activ
process
resist
gondii
depend
upon
effect
immun
respons
gondii
antigen
interest
determin
effect
fivinfect
may
lung
studi
character
chang
occur
bronchoalveolar
lavag
bal
cell
count
differenti
cytokin
mrna
protein
express
cat
infect
fiv
verifi
alter
cytokin
messag
protein
express
associ
product
viral
infect
fivgag
mrna
express
quantit
infect
fiv
vivo
vitro
twentytwo
pathogen
free
spf
neuter
male
cat
obtain
liberti
laboratori
liberti
corner
nj
spf
cat
seroneg
felin
panleukopenia
felin
herpesviru
felin
caliciviru
coronavirus
felin
leukemia
viru
felin
viru
felin
syncytiaform
viru
chlamydia
toxoplasma
ncsu
strain
fiv
origin
isol
natur
infect
cat
north
carolina
state
univers
colleg
veterinari
medicin
describ
detail
elsewher
english
et
al
davidson
et
al
twelv
cat
inocul
fiv
intraven
tcid
cellfre
viru
cultur
supernat
describ
davidson
et
al
remain
cat
sham
inocul
medium
fivinfect
cat
antibodi
posit
commerci
elisa
idexx
westbrook
proviru
posit
pcr
week
postfiv
infect
bronchoalveolar
lavag
bal
perform
previous
describ
hawkin
denicola
et
al
cat
anesthet
ketamin
intub
end
endotrach
tube
posit
within
distal
trachea
lavag
perform
three
aliquot
tube
cat
left
later
recumb
use
volum
mlkg
bodi
weight
steril
phosphatebuff
salin
pb
aliquot
aliquot
pool
total
viabl
bal
cell
count
determin
trypan
blue
dye
exclus
differenti
cell
analys
perform
stain
cytospin
use
differenti
determin
number
per
millilit
duplic
cultur
along
contamin
bal
cell
seed
rpmi
supplement
fetal
bovin
serum
antibiot
contain
amml
follow
overnight
incub
nonadher
cell
remov
wash
hbss
one
cultur
adher
cell
dislodg
aliquot
use
verifi
puriti
alway
determin
differenti
analys
remain
cell
lyse
total
cellular
rna
prepar
quantit
cytokin
gene
express
see
duplic
cultur
cultur
fresh
medium
addit
h
cultur
supernat
harvest
frozen
analyz
tnfa
bioactiv
prepar
describ
normal
spf
cat
infect
vitro
fivncsu
moi
h
total
cytoplasm
rna
cultur
supernat
collect
day
postinfect
frozen
analyz
fivgag
mrna
cytokin
mrna
tnfa
bioactiv
bioactiv
determin
use
murin
plasmacytoma
cell
line
previous
describ
et
al
nordan
potter
serial
twofold
dilut
supernat
assay
made
ml
ad
ml
cell
cultur
plate
control
includ
murin
contain
cell
supernat
posit
control
medium
alon
neg
control
dilut
run
triplic
day
incub
ml
medium
contain
mci
hthymidin
icn
costa
mesa
ca
ad
well
incub
overnight
cell
harvest
incorpor
hthymidin
count
per
minut
measur
use
scintil
counter
unit
per
millilit
uml
reciproc
dilut
supernat
stimul
maxim
count
per
minut
assay
multipli
sinc
assay
volum
ml
tnfa
bioactiv
measur
previous
describ
et
al
laster
et
al
minor
lm
cell
mous
cell
line
sensit
tnf
plate
plate
concentr
cell
ml
cultur
overnight
fifti
microlit
serial
twofold
dilut
cell
supernat
ad
triplic
along
ml
cultur
medium
contain
mgml
actinomycin
serial
dilut
human
recombin
tnfa
ubi
lake
placid
ny
known
bioactiv
use
standard
posit
control
follow
overnight
incub
ml
bromid
mgml
pb
ad
well
follow
h
incub
supernat
remov
ml
hcl
isopropanol
ad
well
min
incub
ml
ddh
ad
well
absorb
measur
nm
elisa
plate
reader
unit
tnfa
determin
standard
curv
deriv
dilut
human
recombin
tnfa
standard
murin
may
either
less
sensit
felin
tnfa
compar
human
recombin
standard
therefor
valu
report
meant
rel
comparison
felin
tnfa
level
cat
timepoint
intend
convey
absolut
quantit
measur
total
cellular
rna
isol
use
guanidinium
thiocyan
techniqu
describ
rottman
et
al
tel
test
b
friendswood
tx
ad
monolay
cell
cell
lyse
pipet
multipl
time
rna
subsequ
isol
accord
kit
instruct
cytokin
mrna
level
quantit
rtqcpcr
method
shown
previous
sensit
accur
reproduc
levi
et
al
rottman
et
al
competit
dna
fragment
consist
linear
array
upstream
downstream
primer
sequenc
ifng
tnfa
separ
dna
spacer
rottman
et
al
primer
pair
yield
competitor
product
base
pair
differ
cdna
product
second
base
pair
competit
dna
fragment
construct
allow
fivgag
mrna
rtqcpcr
fivgag
primer
chosen
sequenc
ncsu
isol
molecular
clone
yang
et
al
follow
revers
transcript
rna
sampl
equal
amount
cdna
use
cytokin
primer
pair
serial
dilut
dna
competit
fragment
amol
pcr
product
separ
electrophoresi
agaros
gel
stain
ethidium
bromid
photograph
nm
uv
transillumin
polaroid
camera
imag
acquir
use
adob
photoshop
analyz
use
nih
imag
softwar
program
log
cytokin
plot
log
number
copi
competitor
sampl
result
cytokin
copi
number
x
intercept
constitut
mrna
express
measur
cytokin
present
ratio
cytokin
allow
quantit
comparison
cytokin
anim
comparison
result
fivinfect
uninfect
cat
perform
use
nonparametr
analysi
wilcoxon
rank
test
differ
infect
uninfect
cat
consid
p
comparison
gag
express
cat
within
fivinfect
group
made
use
student
ttest
alpha
level
expect
spf
cat
infect
fivncsu
becam
pcr
proviru
peripher
blood
mononuclear
cell
pbmc
develop
antibodi
gag
protein
week
infect
data
shown
fivinfect
cat
demonstr
progress
declin
peripher
blood
ratio
secondari
decreas
cell
increas
cell
fig
characterist
infect
fiv
similar
previous
report
experiment
infect
ncsu
viru
isol
english
et
al
davidson
et
al
yang
et
al
tompkin
et
al
examin
cell
popul
clearli
show
total
cell
count
deriv
infect
control
group
vari
appreci
throughout
cours
experi
fig
indic
fiv
infect
spf
cat
alon
result
measur
chang
pulmonari
cell
number
differenti
count
recov
bal
popul
control
fivinfect
cat
demonstr
hiv
infect
induc
activ
accompani
elabor
number
cytokin
tnfa
agostini
et
al
deni
ghadirian
trentin
et
al
twigg
et
al
determin
fiv
infect
caus
similar
activ
bal
cell
collect
fivinfect
control
cat
constitut
cytokin
product
measur
alveolar
macrophag
fivinfect
cat
produc
greater
level
bioactiv
tnfa
p
p
week
postfiv
infect
control
cat
fig
similarli
fivinfect
cat
elev
bioactiv
p
p
week
postfiv
infect
fig
increas
constitut
tnfa
secret
coincid
chang
subset
circul
fig
week
postinfect
ratio
stabil
still
remain
level
constitut
tnfa
fig
p
fig
p
product
limit
avail
bioassay
elisa
felin
cytokin
alter
cytokin
assess
quantit
chang
mrna
level
use
rtqcpcr
tnfa
evalu
monokin
import
initi
regul
innat
acquir
immun
part
tnfa
mrna
express
correl
bioactiv
protein
product
fig
b
alveolar
macrophag
fivinfect
cat
elev
tnfa
mrna
level
border
statist
week
p
week
p
postfiv
infect
week
postfiv
infect
tnfa
mrna
level
similar
control
anim
mrna
express
fivinfect
cat
peak
week
postfiv
infect
fig
p
declin
control
level
week
postfiv
infect
control
cat
consist
express
lower
level
mrna
fivinfect
cat
throughout
experi
fig
although
gener
consid
product
activ
lymphocyt
ifng
express
mrna
bioactiv
protein
macrophag
experiment
document
model
system
munder
et
al
nugent
et
al
therefor
investig
abil
fivinfect
cat
produc
ifng
contrast
control
cat
fivinfect
cat
produc
high
level
ifng
mrna
unlik
cytokin
ifng
mrna
level
increas
progress
cours
infect
fig
p
week
p
week
tabl
show
number
fivinfect
cat
express
ifng
mrna
also
increas
time
wherea
ifng
mrna
detect
one
control
cat
one
time
point
week
postfiv
infect
thu
fivinduc
chang
ifng
mrna
express
manifest
timerel
increas
number
cat
express
ifng
mrna
well
increas
level
express
individu
cat
tabl
show
collect
control
cat
consist
maintain
low
measur
constitut
mrna
express
timepoint
contrast
tabl
fiv
cat
demonstr
progress
decreas
mrna
express
time
infect
progress
decreas
number
cat
detect
mrna
compar
group
fivinfect
cat
express
less
p
mrna
control
cat
week
data
shown
howev
fivinfect
cat
maintain
mrna
express
level
similar
seen
control
cat
data
shown
fivgag
mrna
detect
either
control
fivinfect
group
cat
fiv
infect
follow
fiv
infect
steadi
increas
fivgag
express
cours
infect
peak
gag
mrna
express
occur
week
postfiv
infect
fig
increas
gag
mrna
due
tabl
number
cat
constitut
mrna
express
week
postfiv
infect
fiv
fig
quantit
constitut
fivgag
mrna
express
collect
fivinfect
cat
alveolar
macrophag
plastic
adher
total
cytoplasm
rna
extract
analyz
rtqcpcr
util
oligoprim
fiv
fivgag
mrna
detect
control
cat
anytim
fivinfect
cat
fiv
infect
data
repres
mean
ae
e
fivgag
ratio
fivinfect
cat
increas
fivgag
mrna
express
throughout
experi
week
p
week
p
absolut
increas
rna
express
individu
cat
cat
express
detect
mrna
throughout
experi
data
suggest
constitut
cytokin
express
recov
fivinfect
cat
direct
respons
fiv
infect
test
directli
normal
cat
infect
fiv
vitro
tnfa
mrna
protein
assay
fig
indic
cultur
absenc
viru
produc
littl
tnfa
fig
b
fig
mrna
protein
even
day
cultur
wherea
infect
fiv
produc
level
tnfa
messag
fig
c
day
infect
protein
fig
day
infect
addit
irradi
fiv
cultur
fail
induc
cytokin
respons
data
shown
suggest
viru
infectiondepend
process
support
conjectur
fivgag
mrna
easili
detect
infect
live
fiv
irradi
viru
either
day
infect
data
shown
consider
evid
cellular
cytokin
may
play
role
clinic
manifest
hivassoci
pulmonari
diseas
howev
report
cellular
cytokin
chang
hivinfect
patient
controversi
clear
alter
express
tnfa
pulmonari
compart
associ
hiv
infect
agostini
et
al
deni
ghadirian
trentin
et
al
twigg
et
al
known
whether
intrins
characterist
viral
infect
pulmonari
cell
due
cofactor
secondari
opportunist
infect
studi
address
question
cellular
chang
cytokin
express
pulmonari
compart
fivinfect
spf
cat
lentiviru
anim
model
interpret
result
confound
potenti
exposur
secondari
pathogen
total
cell
count
absolut
number
lymphocyt
eosinophil
similar
fivinfect
control
group
although
studi
hivinfect
patient
report
differ
total
cell
count
number
rankin
et
al
meltzer
et
al
other
report
increas
beck
shellito
agostini
et
al
agostini
et
al
report
increas
number
approxim
onethird
hivinfect
patient
whether
concurr
opportunist
infect
failur
demonstr
decreas
number
hivinfect
patient
fivinfect
cat
suggest
high
incid
opportunist
pulmonari
diseas
lentivir
infect
due
numer
macrophag
lung
consist
cytolog
featur
bal
fivinfect
cat
neutrophilia
week
postfiv
infect
similarli
increas
distinct
cell
popul
includ
neutrophil
lymphocyt
macrophag
also
report
hivinfect
patient
case
without
alter
total
cell
count
agostini
et
al
davi
et
al
pulmonari
neutrophilia
accompani
either
system
neutrophilia
clinic
symptom
ill
bacteri
contamin
neutrophilia
relat
fiv
infect
result
secondari
bacteri
pneumonia
also
pulmonari
neutrophilia
develop
control
cat
neutrophilia
observ
fivinfect
cat
result
sequenti
bal
neutrophilia
bal
popul
report
cat
asymptomat
stage
rang
month
year
fiv
infect
hawkin
et
al
similar
neutrophilia
report
later
stage
hiv
infect
agostini
et
al
cador
et
al
cador
et
al
also
report
neutrophil
alveol
cat
natur
infect
fiv
suffer
number
secondari
complic
mechan
regul
recruit
neutrophil
lung
like
releas
macrophagederiv
cytokin
perhap
respons
secondari
infect
human
found
increas
patient
infect
deni
ghadirian
studi
evalu
chemokin
express
howev
would
unreason
expect
constitut
cytokin
releas
exhibit
fivinfect
cat
tnfa
ifng
would
also
includ
chemokin
import
differ
bal
cell
popul
fivand
hivinfect
subject
failur
fivinfect
cat
develop
pulmonari
lymphocytosi
characterist
hiv
infect
agostini
et
al
differ
absolut
number
lymphocyt
fivinfect
control
cat
lymphocyt
never
contribut
total
bal
cell
popul
base
upon
absolut
lymphocyt
count
patient
earli
hiv
infect
patient
advanc
diseas
show
increas
number
lymphocyt
particularli
lymphocyt
lung
agostini
et
al
cell
thought
involv
host
defens
mechan
hiv
beck
shellito
studi
previou
studi
shown
fivinfect
cat
develop
popul
activ
cell
peripher
circul
jeng
et
al
bucci
et
al
hawkin
et
al
present
studi
show
number
lymphocyt
recover
pulmonari
immun
compart
bal
absenc
lymphocyt
alveol
fivinfect
cat
due
failur
develop
activ
lymphocyt
circul
one
possibl
explan
differ
hiv
fiv
recruit
cell
lung
could
relat
level
viru
express
lung
cat
versu
express
viral
antigen
lung
hivinfect
patient
although
studi
quantit
fivgag
mrna
express
determin
actual
antigen
express
locat
within
lung
perform
et
al
fiv
mrna
situ
hybrid
small
fraction
total
bal
cell
popul
studi
determin
extent
fiv
antigen
present
interstiti
lung
tissu
report
altern
possibl
pulmonari
lymphocytosi
characterist
hivinfect
patient
respons
subclin
secondari
pulmonari
infect
would
occur
fivinfect
spf
cat
maintain
isol
facil
support
cador
et
al
describ
interstiti
pneumon
cat
natur
infect
fiv
suffer
varieti
infecti
diseas
complic
pneumon
character
neutrophil
lymphocyt
alveol
also
recent
observ
fivinfect
cat
larg
number
activ
cell
circul
observ
lung
unless
expos
secondari
pulmonari
pathogen
follow
exposur
fivinfect
cat
gondii
rapid
day
activ
cell
pulmonari
compart
seen
normal
cat
challeng
gondii
unpublish
observ
constitut
elabor
cytokin
fivinfect
cat
show
mani
similar
hivinfect
counterpart
express
tnfa
mrna
initi
upregul
acut
stage
infect
decreas
near
control
level
week
postfiv
infect
elabor
bioactiv
tnfa
protein
still
evid
week
postinfect
experi
interrupt
week
postfiv
infect
known
low
level
constitut
tnfa
activ
would
remain
eventu
return
normal
level
howev
levi
et
al
report
elev
express
tnfa
mrna
lymph
node
cell
fivinfect
cat
long
month
postinfect
alveolar
macrophag
clinic
healthi
asymptomat
diseas
arc
aid
hivinfect
patient
produc
constitut
tnfa
bioactiv
protein
throughout
cours
hiv
infect
israelbiet
et
al
krishnan
et
al
millar
et
al
contrast
rise
fall
tnfa
mrna
level
ifng
mrna
express
fivinfect
cat
continu
increas
throughout
experi
experi
plastic
adher
util
bal
cell
popul
eosinophil
neutrophil
lymphocyt
wherea
puriti
differenti
analysi
least
remain
possibl
cell
type
respons
ifng
express
contamin
lymphocyt
would
seem
lead
candid
howev
lymphocyt
rare
ever
demonstr
postplast
adher
differenti
predomin
contamin
cell
type
eosinophil
eosinophil
demonstr
elabor
ifng
mrna
model
system
woerli
et
al
howev
level
ifng
mrna
demonstr
cultur
independ
level
less
eosinophil
contamin
reason
coupl
preced
macrophag
deriv
ifng
literatur
munder
et
al
nugent
et
al
consid
mostlik
sourc
ifng
mrna
increas
ifng
mrna
similar
report
peripher
blood
lymph
node
hivinfect
patient
graziosi
et
al
graziosi
et
al
et
al
fivinfect
cat
levi
et
al
dean
pedersen
yet
determin
hivinfect
patient
constitut
produc
ifng
subsequ
studi
show
fact
sourc
ifng
mrna
diminish
fact
ifng
mrna
level
detect
fivinfect
cat
also
possibl
increas
cytokin
product
fivinfect
cat
due
vitro
manipul
previous
sensit
cell
howev
normal
cat
collect
cultur
vitro
parallel
fivinfect
cat
support
conclus
elev
cytokin
product
latter
group
due
fiv
infect
artifact
cultur
alveolar
macrophag
fivinfect
cat
lost
abil
produc
mrna
week
postfiv
infect
somewhat
differ
hiv
infect
exhibit
low
level
constitut
product
deni
ghadirian
despit
constitut
product
hivinfect
stimul
aureu
increas
product
control
deni
ghadirian
similarli
levi
et
al
report
fivinfect
cat
cochalleng
gondii
respond
increas
mrna
express
lymph
node
gondii
challeng
control
cat
therefor
quantit
cytokin
mrna
express
lung
lymph
node
fivinfect
cat
indic
suscept
gondii
may
due
least
part
inabl
gener
immun
respons
lung
interestingli
number
cat
studi
without
detect
mrna
express
correl
well
expect
mortal
rate
previous
report
fivncsu
gondii
cochalleng
model
davidson
et
al
yang
et
al
vitro
infect
fiv
also
induc
express
tnfa
express
hiv
macrophag
lymphocyt
close
relat
cellular
activ
cytokin
signal
kazazi
et
al
poli
et
al
b
serpent
et
al
studi
fivgag
express
increas
throughout
experi
correl
tnfa
express
peak
week
postfiv
infect
interestingli
ifng
cytokin
express
kinet
similar
fivgag
express
suggest
mechan
regul
express
tnfa
differ
regul
ifng
upregul
cytokin
depend
upon
viru
replic
fiv
infect
vitro
induc
cytokin
mrna
protein
synthesi
wherea
exposur
irradi
viru
fail
induc
either
cytokin
mrna
protein
progress
increas
viru
burden
also
differ
markedli
transient
acut
stage
week
high
viru
burden
plasma
pbmc
jeng
et
al
observ
support
conjectur
macrophag
may
major
viru
reservoir
asymptomat
stage
infect
mrna
synthesi
also
elev
acut
stage
infect
howev
similar
tnfa
peak
express
correl
viru
burden
continu
increas
fivgag
ifng
mrna
presenc
high
level
somewhat
unexpect
potent
inhibitor
hiv
replic
akridg
et
al
weissman
et
al
well
macrophag
cytokin
express
gazzinelli
et
al
murray
et
al
howev
present
level
inhibit
tnfa
synthesi
actual
augment
tnfa
mediat
hiv
express
weissman
et
al
fiv
replic
may
similarli
regul
howev
addit
studi
need
resolv
question
concurr
upregul
ifng
consist
recent
observ
fiv
hiv
caus
upregul
ifng
tnfa
well
cytokin
suppress
cytokin
levi
et
al
dean
pedersen
graziosi
et
al
graziosi
et
al
et
al
data
report
herein
indic
fivinfect
cat
similar
constitut
cytokin
report
lymph
node
cell
pbmc
fivinfect
cat
hivinfect
patient
standpoint
immunoprotect
intracellular
pathogen
level
protect
tnfa
ifng
nonprotect
cytokin
elev
hiv
patient
fivinfect
cat
suscept
intracellular
pathogen
suggest
simpli
appear
protect
cytokin
exclus
nonprotect
cytokin
rel
level
cytokin
quantiti
time
appear
support
concurr
increas
decreas
mrna
express
fivinfect
cat
shown
predict
suscept
fivinfect
cat
gondii
levi
et
al
fivt
gondii
coinfect
thu
provid
power
model
dissect
role
cytokin
pulmonari
fivand
hivinfect
patient
